arrow
F

Francesco Fiorentino

Sapienza University of Rome
H指数:22
被引数:1,582

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of High-Affinity CHD1 Chromodomain Inhibitors

高亲和力CHD1染色质结构域抑制剂的研发

2026-05-050
OA
Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells

联苯取代的尿嘧啶基羟肟酸(UBHAs)作为具有促凋亡活性的强效HDAC抑制剂在白血病和前列腺癌细胞中的开发

2026-04-300
OA
A synergistic interaction between PRMT5 and LSD1 inhibitors in AML

PRMT5与LSD1抑制剂的协同作用在AML中

2026-03-270
OA
The ATC12 small molecule inhibits the Aurora-A/TPX2 interaction and impairs the proliferation of breast cancer cells
2026-03-240
OA
Simplification and Derivatization of Quinoline-Containing M41 Lead to the Discovery of NADPH Oxidase Isoform-Selective Inhibitors Effective in Cancer Cells

喹啉基M41的简化与衍生化导致NADPH氧化酶同工酶选择性抑制剂在癌细胞中的发现

2026-01-010
OA
Structural snapshots of Pseudomonas aeruginosa LptB2FG and LptB2FGC reveal insights into lipopolysaccharide recognition and transport

铜绿假单胞菌(Pseudomonas aeruginosa) LptB2FG 和 LptB2FGC 的结构快照揭示了脂多糖(lipopolysaccharide)识别和运输的见解

2025-12-170
OAAI
Structural characterisation of the fungal Pmt4 homodimer

真菌Pmt4同源二聚体的结构表征

2025-12-140
OAAI
Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710

更正:Sennato et al. 使用唾液酸模拟物(F9-PEG)修饰的阳离子脂质体复合物的优化,以靶向C1858T PTPN22变异体,用于内分泌自身免疫性疾病的新型免疫疗法的临床前评估。Pharmaceutics 2025, 17, 710

2025-12-120
OAAI
A C3-Symmetric Diphenylethylendiamine-Based Catalyst in the Asymmetric Michael Addition of α,β-Unsaturated Ketones with 4-Hydroxycoumarin and 4-Hydroxyquinolin-2-One

一种基于C3-对称二苯基亚乙二胺的催化剂在α,β-不饱和酮与4-羟基香豆素和4-羟基喹啉-2-酮的不对称Michael加成反应中

2025-08-130
PREAI
One-Year Prognostic Differences and Management Strategies between ST-Elevation and Non-ST-Elevation Myocardial Infarction: Insights from the PRAISE Registry

一年预后差异及ST段抬高与非ST段抬高心肌梗死的管理策略:PRAISE注册研究的见解

2025-06-240
PRE
(Heteroarylmethyl)benzoic Acids as a New Class of Bacterial Cystathionine γ-Lyase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling

(杂芳基甲基) 苯甲酸作为一类新的细菌胱硫醚 γ-裂解酶抑制剂: 合成,生物学评估和分子建模

2024-05-211
PRE